Stock Track | Nanobiotix (NBTX) Surges 6.51% After-Hours Following Leerink Partners' Bullish $24 Price Target

Stock Track10-02

Shares of Nanobiotix (NBTX), a biotechnology company, soared 6.51% in after-hours trading on Wednesday, building on positive sentiment from a bullish analyst report. The stock's movement comes as investors react to Leerink Partners' reaffirmation of its Buy rating on the company.

Leerink Partners analyst Jonathan Chang maintained a Buy rating on Nanobiotix and set an ambitious price target of $24.00. This target suggests significant upside potential from the stock's current trading levels, likely contributing to the after-hours rally.

The sustained positive outlook from a respected Wall Street firm appears to have bolstered investor confidence in Nanobiotix's prospects. While specific details of Chang's analysis were not provided, the maintained Buy rating and high price target imply a strong belief in the company's future performance and potential market opportunities. Investors will be watching closely to see if this after-hours momentum carries into regular trading sessions and whether other analysts follow suit with similarly optimistic views on Nanobiotix.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1168961084?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-02 04:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168961084","market":"nz","top_or_hot":-1,"title":"Stock Track | Nanobiotix (NBTX) Surges 6.51% After-Hours Following Leerink Partners' Bullish $24 Price Target","media":"Stock Track","content":"<p>Shares of Nanobiotix (NBTX), a biotechnology company, soared 6.51% in after-hours trading on Wednesday, building on positive sentiment from a bullish analyst report. The stock's movement comes as investors react to Leerink Partners' reaffirmation of its Buy rating on the company.</p>\n\n<p>Leerink Partners analyst Jonathan Chang maintained a Buy rating on Nanobiotix and set an ambitious price target of $24.00. This target suggests significant upside potential from the stock's current trading levels, likely contributing to the after-hours rally.</p>\n\n<p>The sustained positive outlook from a respected Wall Street firm appears to have bolstered investor confidence in Nanobiotix's prospects. While specific details of Chang's analysis were not provided, the maintained Buy rating and high price target imply a strong belief in the company's future performance and potential market opportunities. Investors will be watching closely to see if this after-hours momentum carries into regular trading sessions and whether other analysts follow suit with similarly optimistic views on Nanobiotix.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Nanobiotix (NBTX) Surges 6.51% After-Hours Following Leerink Partners' Bullish $24 Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Nanobiotix (NBTX) Surges 6.51% After-Hours Following Leerink Partners' Bullish $24 Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-02 04:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Nanobiotix (NBTX), a biotechnology company, soared 6.51% in after-hours trading on Wednesday, building on positive sentiment from a bullish analyst report. The stock's movement comes as investors react to Leerink Partners' reaffirmation of its Buy rating on the company.</p>\n\n<p>Leerink Partners analyst Jonathan Chang maintained a Buy rating on Nanobiotix and set an ambitious price target of $24.00. This target suggests significant upside potential from the stock's current trading levels, likely contributing to the after-hours rally.</p>\n\n<p>The sustained positive outlook from a respected Wall Street firm appears to have bolstered investor confidence in Nanobiotix's prospects. While specific details of Chang's analysis were not provided, the maintained Buy rating and high price target imply a strong belief in the company's future performance and potential market opportunities. Investors will be watching closely to see if this after-hours momentum carries into regular trading sessions and whether other analysts follow suit with similarly optimistic views on Nanobiotix.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NBTX","symbol_name":"NANOBIOTIX SPON ADS EACH REP 1 ORD SHS","start_time":0,"source_url":"","article_id":"1168961084","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168961084","pubTimestamp":1759350735,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Nanobiotix (NBTX), a biotechnology company, soared 6.51% in after-hours trading on Wednesday, building on positive sentiment from a bullish analyst report. The stock's movement comes as...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NBTX":"NANOBIOTIX SPON ADS EACH REP 1 ORD SHS"},"translate_title":"股票追踪|Leerink Partners看涨24美元目标价后，Nanobiotix(NBTX)盘后飙升6.51%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NBTX":1},"content_text":"Shares of Nanobiotix (NBTX), a biotechnology company, soared 6.51% in after-hours trading on Wednesday, building on positive sentiment from a bullish analyst report. The stock's movement comes as investors react to Leerink Partners' reaffirmation of its Buy rating on the company.\nLeerink Partners analyst Jonathan Chang maintained a Buy rating on Nanobiotix and set an ambitious price target of $24.00. This target suggests significant upside potential from the stock's current trading levels, likely contributing to the after-hours rally.\nThe sustained positive outlook from a respected Wall Street firm appears to have bolstered investor confidence in Nanobiotix's prospects. While specific details of Chang's analysis were not provided, the maintained Buy rating and high price target imply a strong belief in the company's future performance and potential market opportunities. Investors will be watching closely to see if this after-hours momentum carries into regular trading sessions and whether other analysts follow suit with similarly optimistic views on Nanobiotix.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1168961084","isCrawlerRequest":true}